Grace Therapeutics Inc
GRCE·Stocks·Pharmaceuticals Major·United States·Nasdaq·USD
Price
$0.94
Today
-0.5%
YTD
+0.0%
About
With headquarters in Laval, Canada, Acasti Pharma is a biotechnology company, in operation since 2002. The company works to develop and commercialise pharmaceutical applications of its licensed rights for cardiovascular diseases. With an eye towards US sales, Acasti Pharma is currently listed on the NASDAQ CM stock exchange under the ticker ACST. Add this stock to your eToro watchlist today to track ACST share price movements.
Price chart
Closing price history for GRCE (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-2.55
P/S (TTM)0.00
P/B (TTM)0.53
Market cap$31.54M
Cap tierMicro-cap
Industry avg P/E-43.26
Profitability
Gross margin65.22%
EBIT margin0.00%
Net marginUnknown
ROE-11.94%
ROA-9.81%
Earnings & Revenue
Revenue (TTM)$0.00
Revenue growth (1Y)-100.0%
EPS (TTM)-$0.48
Free cash flow$-8.94M
Total debt$0.00
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)0.68
Employees5
Next earnings20 Jun '25
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.